Abiopharma

🔍 Swaminathan Balaji (Director)

Company: reAlpha Tech Corp. (AIRE)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Acquired 13,074 shares of Common Stock (Direct)
  Date: 2026-07-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,644.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents shares of common stock issued to the reporting person as quarterly compensation for the quarter ended June 30, 2026, for services as a non-executive director under the issuer's director compensation policy pursuant to its 2022 Equity Incentive Plan, as amended. The number of shares awarded was determined based on the 10-day volume weighted average closing price of the issuer's common stock, as reported on The Nasdaq Stock Market LLC, for the period ending on and including July 30, 2026, which was $1.4341.